BIOH12011 - PATHOPHYSIOLOGY AND PHARMACOLOGY 1
EXAM QUESTIONS AND ANSWERS WITH COMPLETE
SOLUTIONS GRADED A++ LATEST UPDATE
Absorption
The process by which nutrient molecules pass through the wall of the digestive system
into the blood
adverse drug reaction
any unexpected, unintended, undesired, or excessive response to a medication given at
therapeutic dosages (as opposed to overdose)
Aetiology
the study of causation, or origination
affinity
The attraction a receptor has for an agonist or antagonist. A measure of the goodness
of fit between a receptor and a drug. Can also describe the attraction an enzyme has for
a substrate.
Agonist
a molecule that, by binding to a receptor site, stimulates a response
allergic reaction
An immunologic hypersensitivity reaction resulting from the unusual sensitivity of a
patient to a particular medication; a type of adverse drug event.
Antagonist
, a drug that can bind to a receptor but does not activate it. Sometimes the word 'blocker'
is used to describe this action.
Apoptosis
process of programmed cell death
atrophy
Reduction in size or wasting away of an organ or cell resulting from disease or lack of
use.
Bioavailability
A measure of the extent of drug absorption for a given drug and route (from 0% to
100%).
Bioequivalence
relative therapeutic effectiveness of chemically equivalent drugs.
Brand name preparations
From the pharmaceutical company that markets the medicine
cell adaptation
Ability of cells to change their structure and function in response to different stimuli or
environmental changes.
Clinical Manifestations
signs and symptoms or evidence of disease
competitive inhibition
Inhibition of an enzyme's ability to catalyze a chemical reaction via a non-reactant
molecule that competes with the substrate(s) for access to the active site.
Distribution
EXAM QUESTIONS AND ANSWERS WITH COMPLETE
SOLUTIONS GRADED A++ LATEST UPDATE
Absorption
The process by which nutrient molecules pass through the wall of the digestive system
into the blood
adverse drug reaction
any unexpected, unintended, undesired, or excessive response to a medication given at
therapeutic dosages (as opposed to overdose)
Aetiology
the study of causation, or origination
affinity
The attraction a receptor has for an agonist or antagonist. A measure of the goodness
of fit between a receptor and a drug. Can also describe the attraction an enzyme has for
a substrate.
Agonist
a molecule that, by binding to a receptor site, stimulates a response
allergic reaction
An immunologic hypersensitivity reaction resulting from the unusual sensitivity of a
patient to a particular medication; a type of adverse drug event.
Antagonist
, a drug that can bind to a receptor but does not activate it. Sometimes the word 'blocker'
is used to describe this action.
Apoptosis
process of programmed cell death
atrophy
Reduction in size or wasting away of an organ or cell resulting from disease or lack of
use.
Bioavailability
A measure of the extent of drug absorption for a given drug and route (from 0% to
100%).
Bioequivalence
relative therapeutic effectiveness of chemically equivalent drugs.
Brand name preparations
From the pharmaceutical company that markets the medicine
cell adaptation
Ability of cells to change their structure and function in response to different stimuli or
environmental changes.
Clinical Manifestations
signs and symptoms or evidence of disease
competitive inhibition
Inhibition of an enzyme's ability to catalyze a chemical reaction via a non-reactant
molecule that competes with the substrate(s) for access to the active site.
Distribution
